The effectiveness of the HPV vaccine lies in its administration before the virus enters the body. WHO recommends vaccination between the ages of 9 and 14, emphasising early intervention. In some regions, there is advocacy for vaccination even after the age of 14 or post-delivery.
Notably, there are approximately around 200 variants of HPV, with 15-18 identified as leading to cervical cancer. Some countries extend the vaccine to boys, as it has proven effective against various cancers, including anal cancer.
Apart from vaccination, accurate screening is paramount. Women should undergo cervical cancer screening at least once in their lifetime after the age of 25, with mandatory screenings every three years in some countries. Self-sampling has the potential to enhance accessibility, yet further research on its adoption is needed.
Early detection and treatment, even after HPV infection, prove effective, making cervical cancer into a completely reversible disease with appropriate medical intervention.
In conclusion, embracing vaccination and regular screening is imperative for women worldwide to safeguard against the threat of cervical cancer. The global efforts outlined by WHO, coupled with individual responsibility, can pave the way for a future where cervical cancer becomes a preventable and controllable disease.
Mind and body
Got health concerns you want to share with a doctor? Are you looking for credible answers regarding symptoms, medicines or lifestyle disorders? Write to us on [email protected], and we will get healthcare professionals to answer them.
The writer is a professor with the department of community medicine at Amrita Hospital, Kochi
